224 related articles for article (PubMed ID: 37105436)
1. BL02, a phage against carbapenem- and polymyxin-B resistant Klebsiella pneumoniae, isolated from sewage: A preclinical study.
Liang Z; Shi YL; Peng Y; Xu C; Zhang C; Chen Y; Luo XQ; Li QM; Zhao CL; Lei J; Yuan ZQ; Peng YZ; Song BQ; Gong YL
Virus Res; 2023 Jul; 331():199126. PubMed ID: 37105436
[TBL] [Abstract][Full Text] [Related]
2. Isolation, characterization, therapeutic potency, and genomic analysis of a novel bacteriophage vB_KshKPC-M against carbapenemase-producing Klebsiella pneumoniae strains (CRKP) isolated from Ventilator-associated pneumoniae (VAP) infection of COVID-19 patients.
Mohammadi M; Saffari M; Siadat SD; Hejazi SH; Shayestehpour M; Motallebi M; Eidi M
Ann Clin Microbiol Antimicrob; 2023 Feb; 22(1):18. PubMed ID: 36829156
[TBL] [Abstract][Full Text] [Related]
3. Activity of ceftazidime-avibactam alone and in combination with polymyxin B against carbapenem-resistant Klebsiella pneumoniae in a tandem in vitro time-kill/in vivo Galleria mellonella survival model analysis.
Borjan J; Meyer KA; Shields RK; Wenzler E
Int J Antimicrob Agents; 2020 Jan; 55(1):105852. PubMed ID: 31770627
[TBL] [Abstract][Full Text] [Related]
4. Clinical, biological and genome-wide comparison of carbapenem-resistant Klebsiella pneumoniae with susceptibility transformation to polymyxin B during therapy.
Wang Y; Luo Q; Chen T; Chi X; Zhou Y; Fu H; Lu P; Xiong L; Xiao T; Zheng B; Shen P; Xiao Y
Clin Microbiol Infect; 2023 Oct; 29(10):1336.e1-1336.e8. PubMed ID: 37423426
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
Tian Y; Zhang Q; Wen L; Chen J
Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
[TBL] [Abstract][Full Text] [Related]
6. Isolation, Identification, and Biological Characterization of Phage vB_KpnM_KpVB3 Targeting Carbapenem-Resistant Klebsiella pneumoniae ST11.
Liu S; Xu H; Cao R; Yang Z; Li X
J Glob Antimicrob Resist; 2024 Jun; 37():179-184. PubMed ID: 38561142
[TBL] [Abstract][Full Text] [Related]
7. Carbapenem-resistant hypermucoviscous
Wang Q; Chen M; Ou Q; Zheng L; Chen X; Mao G; Fang J; Jin D; Tang X
Front Cell Infect Microbiol; 2022; 12():1083009. PubMed ID: 36619764
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Dubrovskaya Y; Chen TY; Scipione MR; Esaian D; Phillips MS; Papadopoulos J; Mehta SA
Antimicrob Agents Chemother; 2013 Nov; 57(11):5394-7. PubMed ID: 23959321
[TBL] [Abstract][Full Text] [Related]
9. Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains.
Adaleti R; Nakipoğlu Y; Çalık Ş; Arıcı N; Kansak N; Şenbayrak S; Aksaray S
Acta Microbiol Immunol Hung; 2023 Jun; 70(2):155-160. PubMed ID: 37133999
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Genomic Analysis of Carbapenem-Resistant Klebsiella pneumoniae from Bacteremia in China.
Cienfuegos-Gallet AV; Zhou Y; Ai W; Kreiswirth BN; Yu F; Chen L
Microbiol Spectr; 2022 Apr; 10(2):e0229021. PubMed ID: 35230130
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.
Satlin MJ; Kubin CJ; Blumenthal JS; Cohen AB; Furuya EY; Wilson SJ; Jenkins SG; Calfee DP
Antimicrob Agents Chemother; 2011 Dec; 55(12):5893-9. PubMed ID: 21968368
[TBL] [Abstract][Full Text] [Related]
12. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
Fang Q; Zong Z
mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
[TBL] [Abstract][Full Text] [Related]
13. Insertion sequence mediating mrgB disruption is the major mechanism of polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae isolates from China.
Chen X; Li P; Sun Z; Xu X; Jiang J; Su J
J Glob Antimicrob Resist; 2022 Sep; 30():357-362. PubMed ID: 35817263
[TBL] [Abstract][Full Text] [Related]
14. Resistance evolution of hypervirulent carbapenem-resistant
Jin X; Chen Q; Shen F; Jiang Y; Wu X; Hua X; Fu Y; Yu Y
Emerg Microbes Infect; 2021 Dec; 10(1):1129-1136. PubMed ID: 34074225
[TBL] [Abstract][Full Text] [Related]
15. Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae, São Paulo, Brazil.
Bartolleti F; Seco BM; Capuzzo Dos Santos C; Felipe CB; Lemo ME; Alves Tda S; Passadore LF; Mimica MJ; Sampaio SC; Zavascki AP; Sampaio JL
Emerg Infect Dis; 2016 Oct; 22(10):1849-51. PubMed ID: 27648951
[No Abstract] [Full Text] [Related]
16. Epidemiology of carbapenem-resistant Klebsiella pneumoniae ST15 of producing KPC-2, SHV-106 and CTX-M-15 in Anhui, China.
Zhao H; He Z; Li Y; Sun B
BMC Microbiol; 2022 Nov; 22(1):262. PubMed ID: 36319965
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
18. Interruption of Capsular Polysaccharide Biosynthesis Gene
Yin X; Fang Q; Zong Z
mSphere; 2022 Dec; 7(6):e0051822. PubMed ID: 36377881
[TBL] [Abstract][Full Text] [Related]
19. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanisms Driving the
Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]